Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:HRC

Hill-Rom (HRC) Stock Price, News & Analysis

Hill-Rom logo

About Hill-Rom Stock (NYSE:HRC)

Advanced Chart

Key Stats

Today's Range
$155.96
$155.96
50-Day Range
$155.05
$156.18
52-Week Range
$93.34
$156.22
Volume
N/A
Average Volume
656,912 shs
Market Capitalization
$10.30 billion
P/E Ratio
41.92
Dividend Yield
0.62%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Hill-Rom Holdings, Inc. operates as a medical technology company. The firm focuses on patient care solutions that improve clinical and economic outcomes. It operates through the following segments: Patient Support System, Front Line Care and Surgical Solutions. The Patient Support Systems segment provides bed frames and surfaces, mobility and clinical workflow solutions. The Front Line Care segment offers respiratory care products and sells medical diagnostic equipment and a diversified portfolio of devices. The Surgical Solutions segment supplies surgical products including tables, lights, pendants, positioning devices, various other surgical products and accessories. The company was founded by William A. Hillenbrand on August 7, 1969 and is headquartered in Chicago, IL.

Receive HRC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hill-Rom and its competitors with MarketBeat's FREE daily newsletter.

HRC Stock News Headlines

Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.
Here Are The Best 37 Rom-Coms Ever Made
See More Headlines

HRC Stock Analysis - Frequently Asked Questions

Hill-Rom Holdings, Inc. (NYSE:HRC) posted its earnings results on Friday, November, 5th. The medical technology company reported $1.67 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.47 by $0.20. The company's revenue was up 13.1% on a year-over-year basis.

The following companies are subsidiaries of Hill-Rom: Breathe Technologies, Voalte Inc, Mortara Instrument, Tridien Medical, Trumpf Medical Systems Ltd., Welch Allyn Inc., Virtus Inc., and more.

Based on aggregate information from My MarketBeat watchlists, some other companies that Hill-Rom investors own include Steel Dynamics (STLD), Walt Disney (DIS), NVIDIA (NVDA), PayPal (PYPL), Meta Platforms (META) and Bank of America (BAC).

Company Calendar

Last Earnings
11/05/2021
Today
4/26/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
Health Care Equipment
Current Symbol
NYSE:HRC
Previous Symbol
NYSE:HB
Employees
10,000
Year Founded
1929

Profitability

Trailing P/E Ratio
41.92
Forward P/E Ratio
24.22
P/E Growth
N/A
Net Income
$248.50 million
Pretax Margin
10.03%

Debt

Sales & Book Value

Annual Sales
$3.02 billion
Cash Flow
$9.29 per share
Price / Cash Flow
16.79
Book Value
$28.56 per share
Price / Book
5.46

Miscellaneous

Free Float
65,594,000
Market Cap
$10.30 billion
Optionable
Optionable
Beta
0.55

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSE:HRC) was last updated on 4/27/2025 by MarketBeat.com Staff
From Our Partners